Chromagar MRSA using cephamycin antibiotics is available.
It has been reported that low-level resistant MRSA is difficult to detect in media using oxacillin as a selective agent, and our company proposes "Chromagar MRSA" utilizing cephamycin antibiotics. This medium is an enzyme substrate medium where MRSA grows in a characteristic "purple" color. It can also detect MRSA that does not show a yolk reaction. Additionally, the "Chromagar MRSA / Staphylococcus aureus differential medium," which does not contain antibiotics, can simultaneously isolate other coagulase-positive staphylococci along with MRSA. For the confirmation of MRSA or Staphylococcus aureus, we recommend "Dry Spot Staphytect Plus," which utilizes a latex agglutination reaction.
Inquire About This Product
basic information
MRSA is a strain of Staphylococcus aureus that becomes resistant to antibiotics because it produces a cell wall synthesis enzyme called PBP2' that is difficult for β-lactam antibiotics to bind to. It has been spreading nationwide in Japan since the early 1980s, establishing itself as a nosocomial infection pathogen, and has evolved to become highly resistant or multidrug-resistant due to various antibiotics.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog below or feel free to contact us.
Line up（3）
| Model number | overview |
|---|---|
| 72054 | Chromogenic Agar MRSA Screening Medium |
| 72046 | Chromogenic Agar MRSA Screening Medium |
| 72075 | Chromogenic Agar MRSA/Staphylococcus Aureus Fractionation Medium |
catalog（1）
Download All Catalogs
Company information
Since its establishment in 1944, Kanto Chemical has continued to develop competitive products in four fields: reagents, electronic materials, clinical diagnostic reagents, and chemical products, under a strict quality control system as a comprehensive reagent manufacturer.